DaVita Inc.
DVAHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeHeadquartered within the healthcare sector, DaVita Inc. focuses on Medical Care Facilities services and products. DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company carries a $11.79B market cap, placing it firmly in the large-cap category. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.
Market Cap
$11.79B
Beta
0.80
P/E (TTM)
15.51
P/E (Fwd)
10.71
EPS (TTM)
$11.84
EPS (Fwd)
$17.14
ROE
88.5%
ROA
7.5%
Cash
$688.9M
Total Debt
$13.41B
Free CF
$1.04B
52W Change
41.8%
Annual Financials
Cash vs Debt
Where DVA stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, DVA finished 0.35% below its 150-day moving average ($187.66) and 7.63% above its 200-day moving average ($173.74). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is DVA overbought or oversold?
At the October 20, 2026 close, DVA's RSI(14) was 72.1, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
DaVita Inc. carries $13.41B in total debt against $688.9M in cash reserves — debt is roughly 19.5x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $1.04B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 88.5% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 7.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $11.61B to $13.64B.
DaVita Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for DaVita Inc. and its sector.